388P RENI-1 efficacy and safety of niraparib as first-line maintenance therapy in newly diagnosed ovarian cancer: A prospective, multicenter real-world study, updated in 24-month follow-up
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.10.409